Trial Details

COMPLETED
Basic Information
Clinical ID c3023
Identifier NCT02624037
Trial Title Precision IFX: Using a Dashboard to Individualize Infliximab Dosage
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions OTHER: Individualized Dosage Precision IFX Dashboard
Participant Information
Sponsor Icahn School of Medicine at Mount Sinai
City Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2015-01
Primary Completion Date 2020-10-21
Completion Date 2020-10-21